ES2148967T3 - Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia. - Google Patents

Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia.

Info

Publication number
ES2148967T3
ES2148967T3 ES97919169T ES97919169T ES2148967T3 ES 2148967 T3 ES2148967 T3 ES 2148967T3 ES 97919169 T ES97919169 T ES 97919169T ES 97919169 T ES97919169 T ES 97919169T ES 2148967 T3 ES2148967 T3 ES 2148967T3
Authority
ES
Spain
Prior art keywords
treatment
diagnosis
eclampsy
substances
eclampsia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97919169T
Other languages
English (en)
Inventor
Thomas William Rademacher
Patricia Mclean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rademacher Group Ltd
Original Assignee
Rademacher Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rademacher Group Ltd filed Critical Rademacher Group Ltd
Application granted granted Critical
Publication of ES2148967T3 publication Critical patent/ES2148967T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)

Abstract

ESTA INVENCION SE REFIERE A UNAS SUSTANCIAS Y UNOS PROCEDIMIENTOS DESTINADOS AL DIAGNOSTICO Y TRATAMIENTO DE LA PREECLAMPSIA Y DE LA DIABETES. SE REFIERE EN ESPECIAL AL PAPEL DE LOS FOSFOGLICANOS DE INOSITOL DE TIPO P (DE LOS IPG) EN LA APARICION DE LA PREECLAMPSIA. EL OBJETIVO DE ESTA INVENCION CONSISTE EN PROCEDIMIENTOS DE DIAGNOSTICO DE LA PREECLAMPSIA QUE PERMITEN LA DETERMINACION DEL NIVEL DE LOS IPG DE TIPO P Y UTILIZAR LOS ANTAGONISTAS DE LOS IPG DE TIPO P PARA EL TRATAMIENTO DE LA PREECLAMPSIA, ASI COMO UN PROCEDIMIENTO DE CRIBADO DE LOS ANTAGONISTAS DE LOS IPG DE TIPO P PARA EL TRATAMIENTO DE LA PREECLAMPSIA, ASI COMO UN PROCEDIMIENTO DE CRIBADO DE LOS ANTAGONISTAS DE LOS IPG DE TIPO P.
ES97919169T 1996-09-11 1997-09-11 Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia. Expired - Lifetime ES2148967T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9618931.1A GB9618931D0 (en) 1996-09-11 1996-09-11 Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes

Publications (1)

Publication Number Publication Date
ES2148967T3 true ES2148967T3 (es) 2000-10-16

Family

ID=10799739

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97919169T Expired - Lifetime ES2148967T3 (es) 1996-09-11 1997-09-11 Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia.

Country Status (14)

Country Link
US (2) US6495330B1 (es)
EP (1) EP0939651B1 (es)
JP (1) JP4457191B2 (es)
CN (1) CN1146445C (es)
AT (1) ATE193452T1 (es)
AU (1) AU715884B2 (es)
BR (1) BR9711752A (es)
CA (1) CA2264939C (es)
DE (1) DE69702209T2 (es)
DK (1) DK0939651T3 (es)
ES (1) ES2148967T3 (es)
GB (1) GB9618931D0 (es)
IL (1) IL128893A0 (es)
WO (1) WO1998010791A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618931D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
GB9618930D0 (en) * 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate lipogenic activity
GB9801899D0 (en) * 1998-01-29 1998-03-25 Univ London Neurotrophic properties of ipgs analogues
CA2321113A1 (en) * 1998-03-18 1999-09-23 Thomas William Rademacher Anti-inositolphosphoglycan monoclonal antibodies
US20040192586A1 (en) * 1998-03-18 2004-09-30 Rodaris Pharmaceuticals Limited Materials and methods relating to anti-inositolphosphoglycan antibodies
GB9806645D0 (en) * 1998-03-27 1998-05-27 Univ London Materials and methods relating to the treatment of conditions involving mast cells,basophils and eosinophils
GB9828564D0 (en) * 1998-12-23 1999-02-17 Rademacher Group Limited Materials and methods for the treatment and diagnosis of cancer
GB9914326D0 (en) * 1999-06-18 1999-08-18 Rademacher Group Limited Materials and methods relating to the diagnosis and treatment of pre-eclampsia
GB9927125D0 (en) * 1999-11-16 2000-01-12 Univ Reading The Placental human neurokinin B precursor
EP1295122A2 (en) * 2000-05-12 2003-03-26 Rodaris Pharmaceuticals Limited Ipg assay
US6953781B2 (en) 2000-05-12 2005-10-11 Rodaris Pharmaceuticals Limited Compounds and their uses
US6716826B2 (en) 2000-05-12 2004-04-06 Rodaris Pharmaceuticals Limited Compounds and their uses
US6939857B2 (en) 2000-05-12 2005-09-06 Rodaris Pharmaceuticals Limited Compounds and their uses
CA2433857C (en) * 2000-05-12 2012-07-31 Rodaris Pharmaceuticals Limited Inositol phosphoglycan derivatives and their medical uses
US6759390B2 (en) 2000-05-12 2004-07-06 Manuel Martin-Lomas Compounds and their uses
EP1409501B1 (en) * 2000-05-12 2008-03-05 Rodaris Pharmaceuticals Limited Inositol phosphoglycan derivatives and their medical uses
GB0015625D0 (en) * 2000-06-26 2000-08-16 Univ London Materials and methods relating for the treatment and diagnosis of pre-eclampsia
AU2004210650C1 (en) * 2003-02-04 2010-01-14 The Administrators Of The Tulane Educational Fund Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
KR20130119506A (ko) * 2004-09-24 2013-10-31 베스 이스라엘 데코니스 메디칼 센터 임신성 합병증의 진단 및 치료 방법
US20120101021A1 (en) 2009-02-06 2012-04-26 Surendra Sharma Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
CA3092163A1 (en) 2018-02-28 2019-09-06 Pharming Intellectual Property B.V. Treatment and prevention of pre-eclampsia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0412700T3 (da) * 1989-08-03 1998-04-06 Univ California Fremgangsmåde til isolering af føtale cytrophoblastceller
GB9618931D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
US20040192586A1 (en) * 1998-03-18 2004-09-30 Rodaris Pharmaceuticals Limited Materials and methods relating to anti-inositolphosphoglycan antibodies

Also Published As

Publication number Publication date
ATE193452T1 (de) 2000-06-15
JP4457191B2 (ja) 2010-04-28
JP2001501598A (ja) 2001-02-06
IL128893A0 (en) 2000-01-31
BR9711752A (pt) 2000-01-18
CA2264939C (en) 2012-06-05
AU715884B2 (en) 2000-02-10
US6495330B1 (en) 2002-12-17
DE69702209T2 (de) 2000-11-09
EP0939651A1 (en) 1999-09-08
DE69702209D1 (de) 2000-07-06
WO1998010791A1 (en) 1998-03-19
CN1235556A (zh) 1999-11-17
EP0939651B1 (en) 2000-05-31
US20030091581A1 (en) 2003-05-15
GB9618931D0 (en) 1996-10-23
AU4310297A (en) 1998-04-02
DK0939651T3 (da) 2000-09-04
CN1146445C (zh) 2004-04-21
CA2264939A1 (en) 1998-03-19

Similar Documents

Publication Publication Date Title
ES2148967T3 (es) Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia.
AU2002366641A1 (en) Methods for inhibiting ocular processes
DE58902029D1 (de) Ladeluftkuehler, dichtung und verfahren zum zusammenbau des ladeluftkuehlers.
MX9803253A (es) Metodo para el tratamiento de colitis establecida utilizando anticuerpos contra il-12.
EP1102988B8 (de) Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür
AU2003217652A8 (en) Methods for continuous performance testing
DE69725606D1 (de) Methoden für die diagnose von allergischen atemwegsaspergillosen
WO1998018430A3 (en) P2y receptor antagonists
GR3029483T3 (en) Antibodies against t-cells as therapeutics
CA2266850A1 (en) Methods and compositions for the diagnosis of extraesophageal gastric reflux
EP1757704A3 (en) Methods for detecting mutations associated with hypertrophic cardiomyopathy
DE69623280T2 (de) Inhibierung der amulin-freisetzung
ZA9710964B (en) Synthetic biepitope compounds which can be used as standards in the biological assays of troponin I
DE69508605D1 (de) Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes
GB9812127D0 (en) Detection of neural activity
DE69927685D1 (de) Verfahren zum screenen von verbindungen mit bioaktivität in organgeweben
ATE253223T1 (de) Verfahren und materialien zur diagnose instabiler angina
AU7269100A (en) Method for indirectly determining the blood-clotting status
ATE274067T1 (de) Verwendung von socs-2 oder cis zum 'screenen' von substanzen, die einen wachstumshormoneffekt verstärken
TR200200207T2 (tr) C. Albicans esas genleri ve antimikotik maddelerin taranması yöntemi
CA2352614A1 (en) Lak activity-screening materials containing lentinus extract of edodes mycelium and lak activity-screening methods using the extract
WO2000014542A3 (de) Diagnostisches verfahren zur erkennung einer pankreasfunktionsstörung
DE69004273T2 (de) Vorrichtung zum Befestigen von Frästrommeln an einem Baggergerät,das für das Ausheben von Gräben im Boden bestimmt ist.
UA28094C2 (uk) Спосіб діагностики загрози перфорації гастродуоденальної виразки
KUBO et al. Urban Landscape Planning and Design Determination of Urban Landscape Identities in Sakai

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 939651

Country of ref document: ES